Decisions Regarding Pregnancy Termination Due to β-Thalassemia Major: a Mixed-Methods Study in Sistan and Baluchestan, Iran.
In the present study, an embedded design was applied in order to conduct a one-year cross-sectional audit of chorionic villus sampling (CVS) and foetal outcomes affected by β-thalassemia major (β-TM) in a prenatal diagnosis (PND) setting. In addition, we explored the decisions regarding pregnancy termination among women whose pregnancy (or child) was affected by β-TM. In the quantitative phase, the available data in the clients' medical records were analysed, while the qualitative phase was performed using a grounded theory method. Interviews were performed with nine pregnant women who had decided against pregnancy termination despite positive CVS results, 11 mothers who had admitted their child to the thalassemia ward for blood transfusion, and 19 mothers who had received positive CVS results and had decided against pregnancy termination in the preceding year. Over one year, 18.6 % of women decided against pregnancy termination despite positive CVS results. Two main themes related to decisions against pregnancy termination emerged from the qualitative data: 1) Cognitive factors (questioning the reliability of the tests or doubts about the accuracy of the results, understanding disease recurrence, curability, perceived severity of the disease, and lack of "real-life experiences"); and 2) Sociocultural responsiveness (family opposition, responsibility before God, and self-responsiveness). All of the mentioned factors could intensify fear of abortion in couples due to possible regret, and encourage a decision against pregnancy termination.
Department of Midwifery, Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. moudi@zaums.ac.ir.
Zahra
Z
Moudi
Department of Genetics, Zahedan University of Medical Sciences, Zahedan, Iran.
Ebrahim
E
Miri-Moghaddam
D000028:Abortion, Induced / Q000523:psychology; D000328:Adult; D005260:Female; D005820:Genetic Testing; D006801:Humans; D007492:Iran; D011247:Pregnancy; D011296:Prenatal Diagnosis; D017086:beta-Thalassemia
Beta-thalassemia major; Declined abortion; Genetic testing; Iran; Prenatal diagnosis
Patient Educ Couns. 2014 Jan;94(1):83-9
24207116
J Adv Nurs. 1997 Sep;26(3):623-30
9378886
J Community Genet. 2013 Apr;4(2):215-21
23296641
Am J Hum Biol. 2002 Mar-Apr;14(2):264-74
11891938
East Mediterr Health J. 2005 May;11(3):308-18
16602449
J Coll Physicians Surg Pak. 2012 Apr;22(4):218-21
22482376
Iran J Public Health. 2012;41(11):67-71
23304678
Prenat Diagn. 2000 May;20(5):378-83
10820404
J Genet Couns. 2008 Dec;17 (6):560-72
18841453
Hemoglobin. 2014;38(3):179-87
24669933
Midwifery. 2014 Oct;30(10):1073-81
23866686
Genet Med. 2012 Jan;14(1):27-38
22237429
Haemophilia. 2004 Jul;10(4):367-9
15230951
J Community Genet. 2013 Oct;4(4):517-22
23467976
BMJ. 2004 Nov 13;329(7475):1134-7
15539666
Prenat Diagn. 1997 May;17(5):423-8
9178316
BMC Public Health. 2011 Mar 30;11:193
21447191
Prenat Diagn. 2012 Oct;32(10 ):954-9
22806755
Neuropsychologia. 2013 Jan;51(1):38-51
23137945
Prenat Diagn. 2006 Sep;26(9):801-9
16927359
BMJ. 2004 Nov 13;329(7475):1115-7
15539644
BMC Med Ethics. 2008 Dec 23;9:19
19105809
Crit Rev Oncol Hematol. 2000 Feb;33(2):105-18
10737372
Health Policy. 1996 Aug;37(2):105-15
10162642
J Community Genet. 2011 Jun;2(2):71-9
22109791
Prenat Diagn. 2006 Mar;26(3):248-57
16475227
Biomed Res Int. 2013;2013:803487
23853772